The activation of the type I interferon (IFN) system is ubiquitous in cases of SLE and pSS, and anti-U1-RNP-containing immune complexes (ICs) have the ability to elicit type I IFNs via Toll-like receptor 7 [20]. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.